Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/07/30 16:22
2014/07/30 16:22
3h
Aegerion reported Juxtapid sales of $36 million in the second quarter, a hair higher than the Street's $35 million consensus estimate. More importantly, Aegerion refined its 2014 Juxtapid sales...
2014/07/30 16:22
2014/07/30 16:22
Latest videos
2014/07/29 19:17
2014/07/29 19:17
1d
SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Galectin Therapeutics Inc.(NASDAQ: GALT)...
2014/07/25 12:22
2014/07/25 12:22
5d
Intercept Pharma Shares Soaring on Positive Liver Disease Study Results (Updated) Shares of Intercept Pharmaceuticals(ICPT) have almost tripled early Thursday morning on the announcement of positive...
2014/07/18 13:58
2014/07/18 13:58
12d
For perspective, here's a chart of the IBB and XBI performance year to date. It's too early to say anything conclusive, of course, but it does look like Yellen may have cut short the biotech recovery...
2014/07/17 15:22
2014/07/17 15:22
13d
NEW YORK (TheStreet) -- Bluebird Bio(BLUE) excited investors last month with the release of data from a clinical trial showing the first two beta-thalassemia patients treated with the gene therapy...
2014/07/10 13:22
2014/07/10 13:22
20d
CAMBRIDGE (TheStreet) -- Duchenne muscular dystrophy is a progressive disease that causes patients to lose muscle function over time. None of the therapies being developed today to treat Duchenne are...
2014/07/04 03:17
2014/07/04 03:17
26d
SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson & Weaver, LLP reminds investors of the July 28, 2014 lead plaintiff deadline in a securities class action lawsuit filed by the firm...
2014/07/30 16:22
2014/07/30 16:22
Latest from Twitter